NMS Group S.p.A.

NMS Group pushes oncology forward, aspiring to lead oncology innovation, research and development with more than 400 staff, the largest and unique organization of its kind in Italy, committed to discovering, developing and delivering life-changing molecules from its robust pipeline worldwide. Beyond its specialization in drug discovery, NMS Group is the only player offering a turnkey, integrated supply chain from preclinical research through First-Time-In-Man clinical phase to production and packaging of finished drugs; Nerviano Medical Sciences srl leads in delivering personalized therapy worldwide, Accelera srl helps partners accelerate their process through preclinical research, and Nerpharma brings active ingredients from formulation to production, closing the full development cycle.